Corteva

CTVA · NYSE · USD

$11.92Change from previous close: −5.17%Absolute change: −$0.65

Close · October 2, 2026

At a glance

Revenue growth
+2.92%
2025 vs 2024
Net income growth
+20.62%
2025 vs 2024
Net margin
6.3%
2024: 5.4%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Income statement · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
Total revenue—4,9053,9102,6186,4564,417
Cost of revenue—2,3722,2541,6442,9322,342
Gross profit—2,5331,6569743,5242,075
Selling, general and administrative—8778427311,156751
Research and development—341413351375335
Operating income—1,155242-2701,832827
EBIT—894-484-3241,856820
EBITDA—1,191-178-24.02,1571,116
Interest expense—36.046.046.052.036.0
Pre-tax income—858-530-3701,804784
Income tax—1337.0-62.0422117
Net income—720-552-3201,314652
Net income to common shareholders—720-552-3201,314652
Basic EPS1.731.07-0.82-0.471.92—
Diluted EPS1.731.07-0.82-0.471.92—
Average shares (basic)669673675679682—
Average shares (diluted)670674675679683—